Global Human Fibrinogen Market Research Report 2024(Status and Outlook)

Global Human Fibrinogen Market Research Report 2024(Status and Outlook)



Report Overview:

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

The Global Human Fibrinogen Market Size was estimated at USD 335.91 million in 2023 and is projected to reach USD 797.47 million by 2029, exhibiting a CAGR of 15.50% during the forecast period.

This report provides a deep insight into the global Human Fibrinogen market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Fibrinogen Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Fibrinogen market in any manner.

Global Human Fibrinogen Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

CSL Behring

LFB Group

Shanghai RAAS Blood Products

Jiangxi Boya Bio-Pharmaceutical

Hualan Biological Engineering

Harbin Pacific Biopharmaceutical

GREEN CROSS

Shanghai XinXing Medical

Octapharma

Market Segmentation (by Type)

Human Fibrinogen Concentrate

Animal Fibrinogen Concentrate

Market Segmentation (by Application)

Congenital Fibrinogen Deficiency

Surgical Procedures

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Human Fibrinogen Market
  • Overview of the regional outlook of the Human Fibrinogen Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Fibrinogen Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Fibrinogen
1.2 Key Market Segments
1.2.1 Human Fibrinogen Segment by Type
1.2.2 Human Fibrinogen Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Fibrinogen Market Overview
2.1 Global Market Overview
2.1.1 Global Human Fibrinogen Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Fibrinogen Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Fibrinogen Market Competitive Landscape
3.1 Global Human Fibrinogen Sales by Manufacturers (2019-2024)
3.2 Global Human Fibrinogen Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Fibrinogen Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Fibrinogen Sales Sites, Area Served, Product Type
3.6 Human Fibrinogen Market Competitive Situation and Trends
3.6.1 Human Fibrinogen Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Fibrinogen Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Fibrinogen Industry Chain Analysis
4.1 Human Fibrinogen Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Fibrinogen Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Fibrinogen Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Fibrinogen Sales Market Share by Type (2019-2024)
6.3 Global Human Fibrinogen Market Size Market Share by Type (2019-2024)
6.4 Global Human Fibrinogen Price by Type (2019-2024)
7 Human Fibrinogen Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Fibrinogen Market Sales by Application (2019-2024)
7.3 Global Human Fibrinogen Market Size (M USD) by Application (2019-2024)
7.4 Global Human Fibrinogen Sales Growth Rate by Application (2019-2024)
8 Human Fibrinogen Market Segmentation by Region
8.1 Global Human Fibrinogen Sales by Region
8.1.1 Global Human Fibrinogen Sales by Region
8.1.2 Global Human Fibrinogen Sales Market Share by Region
8.2 North America
8.2.1 North America Human Fibrinogen Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Fibrinogen Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Fibrinogen Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Fibrinogen Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Fibrinogen Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 CSL Behring
9.1.1 CSL Behring Human Fibrinogen Basic Information
9.1.2 CSL Behring Human Fibrinogen Product Overview
9.1.3 CSL Behring Human Fibrinogen Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Human Fibrinogen SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 LFB Group
9.2.1 LFB Group Human Fibrinogen Basic Information
9.2.2 LFB Group Human Fibrinogen Product Overview
9.2.3 LFB Group Human Fibrinogen Product Market Performance
9.2.4 LFB Group Business Overview
9.2.5 LFB Group Human Fibrinogen SWOT Analysis
9.2.6 LFB Group Recent Developments
9.3 Shanghai RAAS Blood Products
9.3.1 Shanghai RAAS Blood Products Human Fibrinogen Basic Information
9.3.2 Shanghai RAAS Blood Products Human Fibrinogen Product Overview
9.3.3 Shanghai RAAS Blood Products Human Fibrinogen Product Market Performance
9.3.4 Shanghai RAAS Blood Products Human Fibrinogen SWOT Analysis
9.3.5 Shanghai RAAS Blood Products Business Overview
9.3.6 Shanghai RAAS Blood Products Recent Developments
9.4 Jiangxi Boya Bio-Pharmaceutical
9.4.1 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Basic Information
9.4.2 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product Overview
9.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product Market Performance
9.4.4 Jiangxi Boya Bio-Pharmaceutical Business Overview
9.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
9.5 Hualan Biological Engineering
9.5.1 Hualan Biological Engineering Human Fibrinogen Basic Information
9.5.2 Hualan Biological Engineering Human Fibrinogen Product Overview
9.5.3 Hualan Biological Engineering Human Fibrinogen Product Market Performance
9.5.4 Hualan Biological Engineering Business Overview
9.5.5 Hualan Biological Engineering Recent Developments
9.6 Harbin Pacific Biopharmaceutical
9.6.1 Harbin Pacific Biopharmaceutical Human Fibrinogen Basic Information
9.6.2 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Overview
9.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Market Performance
9.6.4 Harbin Pacific Biopharmaceutical Business Overview
9.6.5 Harbin Pacific Biopharmaceutical Recent Developments
9.7 GREEN CROSS
9.7.1 GREEN CROSS Human Fibrinogen Basic Information
9.7.2 GREEN CROSS Human Fibrinogen Product Overview
9.7.3 GREEN CROSS Human Fibrinogen Product Market Performance
9.7.4 GREEN CROSS Business Overview
9.7.5 GREEN CROSS Recent Developments
9.8 Shanghai XinXing Medical
9.8.1 Shanghai XinXing Medical Human Fibrinogen Basic Information
9.8.2 Shanghai XinXing Medical Human Fibrinogen Product Overview
9.8.3 Shanghai XinXing Medical Human Fibrinogen Product Market Performance
9.8.4 Shanghai XinXing Medical Business Overview
9.8.5 Shanghai XinXing Medical Recent Developments
9.9 Octapharma
9.9.1 Octapharma Human Fibrinogen Basic Information
9.9.2 Octapharma Human Fibrinogen Product Overview
9.9.3 Octapharma Human Fibrinogen Product Market Performance
9.9.4 Octapharma Business Overview
9.9.5 Octapharma Recent Developments
10 Human Fibrinogen Market Forecast by Region
10.1 Global Human Fibrinogen Market Size Forecast
10.2 Global Human Fibrinogen Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Fibrinogen Market Size Forecast by Country
10.2.3 Asia Pacific Human Fibrinogen Market Size Forecast by Region
10.2.4 South America Human Fibrinogen Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Fibrinogen by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Human Fibrinogen Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Fibrinogen by Type (2025-2030)
11.1.2 Global Human Fibrinogen Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Fibrinogen by Type (2025-2030)
11.2 Global Human Fibrinogen Market Forecast by Application (2025-2030)
11.2.1 Global Human Fibrinogen Sales (Kilotons) Forecast by Application
11.2.2 Global Human Fibrinogen Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings